Who makes RVT-501 0.5% topical ointment?

RVT-501 0.5% topical ointment is developed by Dermavant Sciences GmbH.

What development phase is RVT-501 0.5% topical ointment in?

RVT-501 0.5% topical ointment is in Phase 1.

Last reviewed 2026-05-13 · How we verify

RVT-501 0.5% topical ointment

Dermavant Sciences GmbH · Phase 1 active Small molecule

At a glance

Generic name	RVT-501 0.5% topical ointment
Sponsor	Dermavant Sciences GmbH
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis (PHASE2)
Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

RVT-501 0.5% topical ointment CI brief — competitive landscape report
RVT-501 0.5% topical ointment updates RSS · CI watch RSS
Dermavant Sciences GmbH portfolio CI